Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 18:21 ET | Source: Base Carbon Inc.

Base Carbon Annual Letter to Shareholders

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp., is pleased to...
March 31, 2026 16:55 ET | Source: HMH Holding Inc.

HMH Holding Inc. Announces Pricing of Initial Public Offering

HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (“HMH”) today announced the pricing of its initial public offering of 10,520,000 shares of its Class A common stock at $20.00 per share....
March 30, 2026 08:55 ET | Source: JBS USA Food Company

JBS USA Food Company Holdings Announces Cash Tender Offers for Up to $1,000.0 Million Combined Aggregate Principal Amount of Its 6.750% Senior Notes Due 2034 and 5.950% Senior Notes Due 2035

GREELEY, Colo., March 30, 2026 (GLOBE NEWSWIRE) -- JBS USA Food Company Holdings announced today the commencement of tender offers (the “Tender Offers”) to purchase for cash a combined aggregate...
March 27, 2026 10:11 ET | Source: Research and Markets

Travel Rewards Credit Card Market Valued at $214.11 Billion in 2026: Analysis of Key Growth Opportunities to 2030

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Travel Rewards Credit Card Market Report 2026" has been added to ResearchAndMarkets.com's offering. The travel rewards credit card market is...
March 27, 2026 00:12 ET | Source: Zenas BioPharma

Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million

WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to...
March 26, 2026 16:01 ET | Source: Zenas BioPharma

Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

WALTHAM, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to...
March 24, 2026 09:00 ET | Source: BioAge Labs, Inc.

BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025

Positive interim Phase 1 data for BGE-102, a potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor, demonstrating potential best-in-class reductions in...
March 23, 2026 16:09 ET | Source: HMH Holding Inc.

HMH Holding Inc. Announces Launch of Initial Public Offering

HOUSTON, March 23, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (“HMH”) today announced that it has launched the initial public offering of 10,520,000 shares of its Class A common stock. The...
March 23, 2026 08:25 ET | Source: Navigator Holdings Ltd.

Navigator Gas Announces Closing of Upsized Secondary Public Offering by Selling Shareholder and Concurrent Repurchase of Shares by Navigator Gas

LONDON, March 23, 2026 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (NYSE: NVGS) (“Navigator Gas,” the “Company,” “we,” or “our”) announced today the closing of the previously announced upsized...
March 23, 2026 08:00 ET | Source: Damora Therapeutics, Inc.

Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

-- Ms. Jarrett brings nearly three decades of executive leadership in biotech, tech and finance -- -- Biotech leaders Dr. Cameron Turtle and Mike Landsittel appointed to Board of Directors -- --...